BERNS PAUL L
Insider CIK 1202769 · ALTH Chief Executive Officer · XNPT Director · JAZZ Director · CLRB Director · ANAC President and CEO, Director · UBX Director · MNLO Director · LYEL 10% owner · EQRX Director · NMRA See Remarks, Director · MTSR Director · KARD Director, 10% owner · ASPE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 1,200,000 | $15.00 | $18.00M | 1,200,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| KARD Kardigan, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 488,090 | $25.61 | $12.50M | 1,426,528 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 9,819 | $3.51 | $34.5K | 7,395,185 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-09 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-11-13 | 2025-11-13 | 4,031 | — | $0 | 4,031 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 24,188 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer deriv | 2025-11-13 | 2025-11-13 | 223,430 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 8,313,680 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 4,031 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 7,523,682 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-13 | 957,559 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 2,000,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 497,049 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 342,500 | — | $0 | 342,500 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 955,864 | — | $0 | 955,864 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 497,049 | — | $0 | 497,049 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 342,500 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 955,864 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | A Award deriv | 2025-05-20 | 2025-05-22 | 24,188 | — | $0 | 24,188 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 13,871 | $1.69 | $23.4K | 7,405,004 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 342,500 | — | $0 | 342,500 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 497,049 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 955,864 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 342,500 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 497,049 | — | $0 | 497,049 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 955,864 | — | $0 | 955,864 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2024-12-27 | 2024-12-27 | 133,097 | — | $0 | 7,551,972 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2024-12-27 | 2024-12-27 | 133,097 | — | $0 | 7,418,875 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2024-12-27 | 2024-12-27 | 133,097 | — | $0 | 7,685,069 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 342,500 | — | $0 | 342,500 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-16 | 171,250 | — | $0 | 7,818,166 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer deriv | 2023-11-09 | 2023-11-09 | 86,344 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer deriv | 2023-11-09 | 2023-11-09 | 101,010 | — | $0 | 0 | SEC↗ |
| EQRX EQRx, Inc. | D To issuer | 2023-11-09 | 2023-11-09 | 627,000 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2023-06-23 | 2023-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2023-01-01 | 2023-01-04 | 453 | — | $0 | 86,344 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2022-09-30 | 2022-10-04 | 101,010 | — | $0 | 101,010 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2022-06-24 | 2022-06-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EQRX EQRx, Inc. | A Award deriv | 2021-12-17 | 2021-12-21 | 85,891 | — | $0 | 85,891 | SEC↗ |
| EQRX EQRx, Inc. | A Award | 2021-12-17 | 2021-12-21 | 627,000 | — | $0 | 627,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2021-08-05 | 2021-08-09 | 1,450 | $154.00 | $223.3K | 8,290 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2020-11-04 | 2020-11-04 | 466 | $147.44 | $68.7K | 13,965 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2020-11-04 | 2020-11-04 | 3,825 | $150.90 | $577.2K | 9,740 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2020-11-04 | 2020-11-04 | 400 | $149.28 | $59.7K | 13,565 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise deriv | 2020-11-02 | 2020-11-04 | 4,691 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise | 2020-11-02 | 2020-11-04 | 4,691 | — | $0 | 14,431 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2020-08-07 | 2020-08-10 | 931 | $125.87 | $117.2K | 9,740 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2020-08-06 | 2020-08-10 | 6,765 | — | $0 | 6,765 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2020-08-06 | 2020-08-10 | 2,705 | — | $0 | 10,671 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2019-08-09 | 2019-08-12 | 726 | $135.65 | $98.5K | 7,966 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2019-08-08 | 2019-08-12 | 4,805 | — | $0 | 4,805 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2019-08-08 | 2019-08-12 | 1,920 | — | $0 | 8,692 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-08-08 | 22,500 | — | $0 | 65,780 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 22,500 | — | $0 | 65,780 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2018-08-10 | 2018-08-13 | 660 | $176.61 | $116.6K | 6,772 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2018-08-09 | 2018-08-13 | 3,735 | — | $0 | 3,735 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2018-08-09 | 2018-08-13 | 1,495 | — | $0 | 7,432 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 3,261 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 3,261 | — | $0 | 3,261 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2017-08-11 | 2017-08-14 | 3 | $144.13 | $432 | 5,937 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2017-08-11 | 2017-08-14 | 659 | $142.36 | $93.8K | 5,940 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2017-08-10 | 2017-08-14 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2017-08-10 | 2017-08-14 | 1,365 | — | $0 | 6,599 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2016-08-15 | 2016-08-17 | 633 | $136.45 | $86.4K | 5,234 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2016-08-11 | 2016-08-15 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2016-08-11 | 2016-08-15 | 1,365 | — | $0 | 5,867 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 394,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 14,584 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 12,890 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 73,788 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer deriv | 2016-06-24 | 2016-06-24 | 84,100 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | D To issuer | 2016-06-24 | 2016-06-24 | 231,311 | $99.25 | $22.96M | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2016-05-17 | 2016-05-19 | 5,000 | — | $0 | 15,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | P Buy deriv | 2016-04-20 | 2016-04-21 | 117,371 | $0.01 | $1.2K | 117,371 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | P Buy | 2016-04-20 | 2016-04-21 | 117,371 | $2.12 | $248.8K | 117,371 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-03-22 | 2016-03-22 | 27,800 | $60.46 | $1.68M | 230,311 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-03-22 | 2016-03-22 | 9,700 | $59.89 | $580.9K | 258,111 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2016-02-03 | 2016-02-05 | 14,584 | — | $0 | 14,584 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2016-02-03 | 2016-02-05 | 73,788 | — | $0 | 73,788 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2016-02-03 | 2016-02-05 | 14,584 | — | $0 | 267,811 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 2,220 | $112.33 | $249.4K | 252,460 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 80 | $110.97 | $8.9K | 254,680 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2016-01-04 | 2016-01-05 | 233 | $112.98 | $26.3K | 252,227 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-12-11 | 2015-12-15 | 6,000 | — | $0 | 294,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-12-11 | 2015-12-15 | 14,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-11 | 2015-12-15 | 590 | $115.52 | $68.2K | 274,170 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-11 | 2015-12-15 | 500 | $118.59 | $59.3K | 254,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-11 | 2015-12-15 | 8,178 | $117.60 | $961.7K | 255,260 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-12-11 | 2015-12-15 | 10,732 | $117.04 | $1.26M | 263,438 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-12-11 | 2015-12-15 | 6,000 | $21.21 | $127.3K | 274,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-12-11 | 2015-12-15 | 14,000 | $5.20 | $72.8K | 268,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-09-15 | 2015-09-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-09-15 | 2015-09-17 | 16,000 | — | $0 | 14,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-09-15 | 2015-09-17 | 4,000 | $5.11 | $20.4K | 258,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-09-15 | 2015-09-17 | 16,000 | $5.20 | $83.2K | 274,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-09-15 | 2015-09-17 | 1,992 | $139.03 | $276.9K | 272,768 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-09-15 | 2015-09-17 | 16,209 | $139.83 | $2.27M | 256,559 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-09-15 | 2015-09-17 | 1,799 | $140.64 | $253.0K | 254,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise deriv | 2015-08-13 | 2015-08-17 | 20,000 | — | $0 | 4,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-08-13 | 2015-08-17 | 3,489 | $137.52 | $479.8K | 269,616 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-08-13 | 2015-08-17 | 11,575 | $139.45 | $1.61M | 254,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-08-13 | 2015-08-17 | 1,655 | $136.49 | $225.9K | 273,105 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | M Exercise | 2015-08-13 | 2015-08-17 | 20,000 | $5.11 | $102.2K | 274,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-08-13 | 2015-08-17 | 3,281 | $138.40 | $454.1K | 266,335 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-08-10 | 2015-08-11 | 797 | $179.98 | $143.4K | 5,593 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2015-08-10 | 2015-08-11 | 4 | $183.36 | $733 | 5,589 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2015-08-07 | 2015-08-11 | 3,415 | — | $0 | 3,415 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2015-08-07 | 2015-08-11 | 1,310 | — | $0 | 6,390 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2015-05-19 | 2015-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2015-05-19 | 2015-05-21 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-27 | 2015-04-28 | 9,750 | $63.85 | $622.5K | 253,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-27 | 2015-04-28 | 3,448 | $62.68 | $216.1K | 263,510 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-27 | 2015-04-28 | 2,100 | $61.74 | $129.7K | 266,958 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-27 | 2015-04-28 | 2,078 | $60.46 | $125.6K | 269,058 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-27 | 2015-04-28 | 7,624 | $59.79 | $455.8K | 271,136 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-24 | 2015-04-28 | 16,267 | $65.51 | $1.07M | 279,660 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-24 | 2015-04-28 | 7,833 | $64.69 | $506.7K | 295,927 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-04-24 | 2015-04-28 | 900 | $66.31 | $59.7K | 278,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | G Gift | 2015-03-20 | 2015-04-28 | 5,000 | — | $0 | 303,760 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2015-03-19 | 2015-03-23 | 37,500 | $56.07 | $2.10M | 308,760 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2015-02-26 | 2015-03-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 84,100 | — | $0 | 84,100 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2015-02-03 | 2015-02-05 | 12,890 | — | $0 | 12,890 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2015-02-03 | 2015-02-05 | 20,260 | — | $0 | 346,260 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | S Sale | 2014-12-26 | 2014-12-29 | 25,000 | $30.82 | $770.5K | 325,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2014-08-12 | 2014-08-14 | 1,087 | $133.15 | $144.7K | 3,993 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2014-08-07 | 2014-08-11 | 3,300 | — | $0 | 3,300 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2014-08-07 | 2014-08-11 | 1,650 | — | $0 | 5,080 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-17 | 2014-06-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2014-06-11 | 2014-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2014-05-15 | 2014-05-16 | 2,500 | $3.66 | $9.2K | 5,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2014-05-14 | 2014-05-16 | 5,000 | — | $0 | 7,500 | SEC↗ |
| XNPT XENOPORT INC | S Sale | 2014-04-24 | 2014-04-24 | 2,500 | $4.30 | $10.8K | 2,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-03-21 | 2014-03-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2014-03-21 | 2014-03-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2014-03-21 | 2014-03-25 | 50,000 | $21.21 | $1.06M | 350,000 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award | 2014-03-21 | 2014-03-25 | 300,000 | $21.21 | $6.36M | 300,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-08-13 | 2013-08-14 | 1,070 | $81.86 | $87.6K | 3,430 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2013-08-08 | 2013-08-12 | 4,500 | — | $0 | 4,500 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2013-08-08 | 2013-08-12 | 2,250 | — | $0 | 4,500 | SEC↗ |
| ANAC Anacor Pharmaceuticals, In | A Award deriv | 2013-06-06 | 2013-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| XNPT XENOPORT INC | M Exercise deriv | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 0 | SEC↗ |
| XNPT XENOPORT INC | M Exercise | 2013-05-16 | 2013-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2013-05-14 | 2013-05-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 1,233,323 | $1.82 | $2.24M | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-08-09 | 2012-08-13 | 4,500 | — | $0 | 4,500 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-08-09 | 2012-08-13 | 2,250 | — | $0 | 2,250 | SEC↗ |
| ANAC Anacor Pharmaceuticals Inc | A Award deriv | 2012-05-30 | 2012-06-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XNPT XENOPORT INC | A Award deriv | 2012-05-16 | 2012-05-17 | 5,000 | — | $0 | 5,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2012-03-09 | 2012-03-13 | 39,200 | $49.56 | $1.94M | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-03-01 | 2012-03-01 | 21,532 | $1.48 | $31.9K | 1,233,323 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-02-29 | 2012-03-01 | 21,163 | $1.52 | $32.2K | 1,254,855 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | A Award | 2012-02-28 | 2012-03-01 | 573,506 | — | $0 | 1,276,018 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-02-24 | 2012-02-27 | 4,350 | $1.55 | $6.7K | 702,512 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | S Sale | 2012-02-23 | 2012-02-27 | 9,100 | $1.56 | $14.2K | 706,862 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer deriv | 2012-01-18 | 2012-01-18 | 4,691 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-01-18 | 2012-01-18 | 4,691 | — | $0 | 4,691 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer | 2012-01-18 | 2012-01-18 | 39,200 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-01-18 | 2012-01-18 | 39,200 | — | $0 | 39,200 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 30,000 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 12,500 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 12,500 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 12,500 | $8.23 | $102.9K | 37,815 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 30,000 | $7.59 | $227.7K | 30,000 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 12,500 | $34.99 | $437.4K | 48,199 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 8,999 | $48.60 | $437.4K | 39,200 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 4,685 | $48.60 | $227.7K | 25,315 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2011-01-11 | 2012-01-13 | 2,116 | $48.60 | $102.8K | 35,699 | SEC↗ |